Products

What will AGI do for Artemisinin?

This classification denotes an antiprotozoal agent with the molecular formula C15H22O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9RMU91N5K2, chemically known as 3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one, octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)- but generally known as artemisinin, which bears US NIH Compound Identifier 68827. artemisinin most often comes in base, type a, and type b forms. European Medicines Agency schedules Artemisinin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05575MIG. The term ARTEMISININ is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules artemisinin in its Anatomical Therapeutic Chemical (ATC) Classification. ARTEMISININ is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule artemisinin under HS 29329985 and SITC 51569. As of Q4 2014, ARTEMISININ remains the US FDA Preferred Term for this commodity. Artemisinin bears US NLM identifiers UMLS ID C0052430 and NCI Concept Code C78093. SMILES: O1OC2(OC3OC(=O)C(C4C13C(C(CC4)C)CC2)C)C.